Moreover, CCL11 has been selected in developing a clinical andproteomics multiple-marker scoring strategy to diagnose obstructive peripheralarterial disease (PAD), and higher concentrations of CCL11 were notably detectedin patients with severe PAD (history of hypertension) [95, 96]. This evidence concerns the gene CCL11 and Hypertension.